Without full access to all available data, both published and unpublished, the current process for conducting systematic reviews of clinical trial evidence “is not sufficiently rigorous, and in some ...

Back in April, a study conducted by the nonprofit Cochrane Group suggested that the $2 billion worth of Roche's ($RHHBY) Tamiflu and other flu fighters stockpiled by ...

There can be no debate about Tamiflu whilst Roche does not keep its promise to release "full study reports" about the drug, argue senior researchers from the Cochrane group. There can be no debate ...

The director of the Nordic Cochrane Centre at the Rigshospitalet, Copenhagen, Denmark, has been expelled from membership of the Governing Board of the Cochrane Collaboration, a position to which he ...